Direct Meds Review: Is It Legit?

Direct Meds is an online telehealth service that sells compounded GLP-1 medication on a monthly plan. The medication, the provider review, nursing support and delivery come in one price.

Here is how it goes. You fill in a brief medical form online. Then you meet a licensed provider, who looks at your health history and your goals. If a GLP-1 fits, the provider sends the prescription to a US compounding pharmacy. The drug ships to your home in temperature-controlled packaging. Refills continue on the same monthly plan.

The menu has four options, all compounded. Semaglutide and tirzepatide each come as sublingual drops or as a weekly injection. There is no brand-name option. Direct Meds says plainly that "These compounded versions of semaglutide are not FDA-approved and may differ in formulation, dosing, and evidence compared to approved injectable products."

For the drugs themselves, read our pages on compounded semaglutide and compounded tirzepatide. Direct Meds serves 48 states; it does not serve Mississippi or Louisiana.

The company behind it is directmeds.com, Inc., which the FDA wrote to at an address in Bluffdale, Utah. The site now lists a mailing address in Houston, Texas, and its terms are governed by Utah law. The Better Business Bureau lists it as Direct Meds LLC, in Salt Lake City, in business since May 6, 2024.

Direct Meds is an operating telehealth company with licensed providers and two named pharmacies, and it has an open FDA warning letter dated September 9, 2025. The weak point is that letter, and shop pages that still list "FDA approved for long term weight loss" as a feature of compounded drugs. The other gap is the pharmacy type: the shop pages say 503B, and the offers page says 503A.

Direct Meds says its medications "are dispensed by U.S.-based 503A compounding pharmacies." That pharmacy type compounds a drug for a named patient on a prescription. State boards regulate it, and it does not register with the FDA the way an outsourcing facility does.

The shop pages say something different: "Pharmacies are US based 503B compounding pharmacies registered with the FDA." They name two. CraftedRx, at 609 N State Hwy 47, Warrenton, Missouri, fills prescriptions in most states. ChemistryRx, at 950 Henderson Blvd., Folcroft, Pennsylvania, fills them in Alabama, California, Connecticut, North Carolina, South Carolina and Washington. Neither name is on the FDA's register of 503B outsourcing facilities, and neither has an FDA warning letter on file.

The site states the molecule and the form for each option, and it says plainly that the drugs are compounded. It answers the question head on: "Yes, both of our GLP-1 weight loss medications are real prescription medications that are prescribed by a doctor and compounded by a real US based pharmacy."

Direct Meds costs $249 a month all-in for compounded semaglutide drops. There is no membership fee, no consultation fee and no shipping fee. The terms add one fee: a $35 disposal fee if you return medication.

The other options cost more: semaglutide injections are $297 a month, tirzepatide drops are $299 a month and tirzepatide injections are $399 a month. The three prices we listed before all held when we read them again.

The shop pages sell each option as a "90 Day Supply" at that monthly price, and say "90-Day Supply Shipped At Once. Billed Monthly." They list no 30-day option. We count that as a three-month commitment: the 90 days of medication ship at once, and the terms give no refund for medication already received.

The "Starting at $147" offer is a discount, not the monthly rate. The offers page says "SAVE $150 instantly", and it also shows "Up to $200 OFF" on both the injections and the oral drops, without saying which order or plan that covers. The shop pages show no discount on the prices they list.

Direct Meds does not bill insurance. The pricing page says it takes HSA and FSA payments and offers bulk pricing on 6- or 12-month plans, with no figure for either. Three months of the drops at the monthly rate total $747, with no fees added.

The price buys the drug, the provider, nursing support and free delivery. It does not buy a low price. Direct Meds ranks 19 of the 21 compounded programs in its group on price, where the median is $179 a month.

Direct Meds tirzepatide injections cost $399 a month. The offers page puts it plainly: "For Tirzepatide we charge $399/month." That price includes the drug, the provider and shipping; there is no membership, consultation or shipping fee. Tirzepatide drops cost $299 a month. The shop pages sell both as a "90 Day Supply" billed monthly.

The offers page shows "Up to $200 OFF" on GLP-1 injections but gives no tirzepatide figure, and the pages we read show no dose ladder that changes the price. The pricing page mentions bulk pricing on 6- or 12-month plans, but gives no tirzepatide figure. Three months at the monthly rate cost three payments of $399. Ask for the bulk figure before you commit to a longer plan. If you have side effects, talk to your provider.

Direct Meds semaglutide comes in two forms at two prices. The pricing page says "Plans start at $249/month for sublingual Semaglutide, and $297/month for injections." Both are monthly prices, with every fee at $0. The shop pages sell both as a "90 Day Supply", billed monthly.

The offers page advertises treatment "Starting at $147" and says "SAVE $150 instantly". The injection's standing rate is set out there too: "For Semaglutide we charge $297/month." The same page shows "Up to $200 OFF" on the oral drops, with no figure for them.

Three months of the drops total $747. For what the drug is, read our compounded semaglutide page.

The care runs through a telehealth visit and a nursing team. After the medical form, you schedule a telehealth appointment with a licensed provider. The provider reviews your case and writes a treatment plan for you.

It moves fast. Direct Meds says you qualify in under 5 minutes and a doctor reviews your chart within 24 hours. If you are approved, the prescription ships "within 1 business day". The offers page says it arrives in 1-2 days.

After that you get a clinical care team, nursing support and digital follow-ups. A medical director oversees a network of state-licensed doctors. One patient on the how-it-works page says "I also love how I can communicate directly with the prescribing doctor with any questions or concerns." Direct Meds does not state whether it asks for labs, and it gives no schedule for follow-ups.

Direct Meds has an open FDA warning letter, dated September 9, 2025. The subject is the unlawful sale of unapproved and misbranded drugs over the internet by a telehealth seller. The FDA wrote that it "has observed that your website offers various compounded drug products, including semaglutide and tirzepatide." It quoted three passages from the site's buying guides that said the compounded drugs use the same active ingredient as the brand-name ones, and wrote: "Your claims imply that your products are the same as an FDA-approved product when they are not." The letter is about marketing claims. It reports no inspection of a pharmacy.

Those three passages were gone ten days later. By September 19, 2025, the semaglutide guide opened with "Important Disclosure: Compounded medications are not FDA-approved." Every guide page still carries that line. The FDA has posted no response letter and no closeout letter, and it has sent Direct Meds no other warning letter.

The shop pages raise the same question again. The semaglutide drops, tirzepatide injection and tirzepatide drops pages list "FDA approved for long term weight loss" and "High bioavailability (89%)" among the features. The tirzepatide injection page also lists an "Easy-to-use, prefilled pen device". The products sold there are compounded, and compounded drugs are not FDA-approved. The FDA's June 2026 guidance to telehealth companies lists claiming that "a compounded drug has been FDA-approved" among the claims it treats as misleading. While the letter is open, we do not link to Direct Meds, and it appears in no ranking.

The bigger question with any compounded program is the drug itself. Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn't review their safety, effectiveness or quality before they're sold, and they are not the same as Wegovy or Zepbound. Formulas can differ from one pharmacy to the next, and some add ingredients such as vitamin B12. Compounding pharmacies are licensed and inspected by state boards of pharmacy; outsourcing facilities (503B) also register with the FDA and are inspected by it. The FDA can issue warning letters when either breaks rules on safety or sterility. Direct Meds puts this on its own site: "Only a licensed provider can determine whether a compounded medication is appropriate for an individual patient."

For side effects, doses and who should not take these drugs, read our pages on semaglutide side effects and tirzepatide side effects, which quote the FDA labels.

You can cancel a subscription up to 48 hours before the next processing date, by turning off auto-refill in your account portal. Direct Meds charges every 30 days and sends a notice 5–7 days before each charge. The offers page adds that month-to-month customers can cancel a shipment by email or phone.

A new prescription order can be canceled only within 24 hours of placing it, and only if the provider network has not received it yet. Canceling a subscription brings no refund for medication you have already received.

The refund rule is narrow. You get a full refund if your prescription is not approved. The terms take back prescription products only in set cases, such as the wrong medication, a damaged product or medication a Direct Meds doctor denied. Returned medication incurs a $35 disposal fee, and issues must be reported to customer service within 48 hours of receipt. The site also mentions a patient satisfaction guarantee, but the terms do not set out its conditions.

Check the plan length before you pay. The shop pages now sell each GLP-1 as a "90 Day Supply" and say "90-Day Supply Shipped At Once. Billed Monthly." They also say "Cancel Anytime" or "No Long-Term Commitment", but not whether the rest of the 90 days is still billed if you cancel. Several one-star reviews on Trustpilot describe charges after a cancellation request. Ask Direct Meds before you order. The offers page also sells subscribe-and-save plans, where customers "agree to a subscription length for stated monthly discount". If you have side effects, talk to your provider.

Budget for the standing rate of $297 a month for the injection, not the $147 promotion.

Direct Meds has a 4.5 TrustScore on Trustpilot from about 17,000 reviews, and 83% of them are five stars. Direct Meds invites customers to review it, and replies to nearly every negative review. The good reviews praise responsive, patient support staff.

The one-star reviews, 8% of the total, describe charges after a cancellation request, orders that did not ship and a backorder with no notice.

On the Better Business Bureau, Direct Meds LLC is not rated and not accredited. It has 281 complaints in the last three years, 209 of them in the last 12 months; the largest groups are product, service, billing and delivery issues. All 281 show a reply from Direct Meds, and 93 are marked resolved.

Trustpilot's score covers every product together. Of the first 20 reviews a "semaglutide" search returns, dated July 29 to October 23, 2026, 11 are five stars and 6 are one star. The good ones praise the support staff; the lower-rated ones describe billing for a three-month supply and charges after a hold request. Three of the 20 describe receiving semaglutide when tirzepatide was ordered.

Direct Meds also publishes 9 reviews on its weight-loss pricing page, about a simple form, a quick doctor review and fast delivery. These are marketing, not results you can expect. This site collects no independent reviews of its own yet.

Our score combines seven checks. Each one counts for a fixed share of the total, listed below. Commission is not an input.

• Price transparency: 10/10 (counts for 20% of the total score). Every price and fee is stated, the promo is apart from the standing rate, and every price held.
• Cost and value: 2/10 (counts for 15% of the total score). Rank 19 of 21 on price, on a three-month plan, no fee load.
• Medication and pharmacy traceability: 9/10 (counts for 15% of the total score). Both pharmacies are named, with an address, and the pharmacy type is stated, but neither pharmacy is on the FDA's outsourcing register.
• Clinical access and oversight: 7.2/10 (counts for 15% of the total score). A fast review, but no lab policy and no follow-up schedule.
• Safety and enforcement: 8/10 (counts for 20% of the total score). An open FDA warning letter on the brand, none on its pharmacies.
• Terms, commitment and refunds: 8.75/10 (counts for 10% of the total score). A 90-day supply billed monthly, which we count as a three-month minimum; the refund rule is stated.
• Availability and fulfillment: 9.88/10 (counts for 5% of the total score). 48 states, free shipping and a stated delivery time.

We rescored Direct Meds on October 24, 2026. Traceability rose from 7.2 to 9 because our record now holds the two pharmacies the shop pages name. Terms fell from 10 to 8.75 because each plan is a 90-day supply billed monthly. The total moved from 7.6 to 7.7. The method is on our methodology page.